The Life Sciences Law & Policy Center supports scholarship at the intersection of law, medicine, and the life sciences — FDA regulation, drug policy, biotechnology and pharmaceutical innovation, health data privacy, bioethics, and the use of artificial intelligence in medicine. This page collects recent work by the Center’s director, by Berkeley Law faculty, and by Berkeley Law students.
Recent Scholarship
Selected recent publications by Berkeley Law faculty and the Center’s director relating to health, medicine, and the life sciences. Berkeley Law authors appear in bold.
Vincent Joralemon, Rethinking Psychedelic REMS, 79 Food & Drug L.J. 1 (forthcoming 2026)
Vincent Joralemon, Sofia Palmieri & I. Glenn Cohen, Chatbots and the Limits of Referral-Based Duties, npj Digital Medicine (forthcoming 2026)
Khiara M. Bridges, Letting Die: Black Maternal and Infant Deaths After Students for Fair Admissions, 114 Calif. L. Rev. (forthcoming 2026)
Vincent Joralemon, Should AI Tell You How to Use Drugs? Lessons from Pharmacist Duty and Harm Reduction, 93 U. Chi. L. Rev. Online 1 (2026)
Vincent Joralemon, The OnlyFans Economy: Intellectual Property’s Pivot from Scarcity to Authenticity, 112 Va. L. Rev. Online 135 (2026)
Julia S. Etkin & Vincent Joralemon, Who Bears Liability When AI Gives Bad Prescribing Advice?, 9 npj Digital Medicine 448 (2026)
Julia Etkin & Vincent Joralemon, Patients Are Seeking Illicit Drug Advice from AI. What Standard of Care Should Apply?, Bill of Health, Harvard Law Petrie-Flom Center (Apr. 2026)
Khiara M. Bridges, Expecting Inequity: How the Maternal Health Crisis Affects Even the Wealthiest Black Americans (MIT Press 2026)
Sofia Palmieri, Vincent Joralemon, Carmel Shachar & I. Glenn Cohen, Digital Addiction Is a Public Health Problem. Is Public Health Law the Solution?, Health Affairs Forefront (Mar. 2026)
Vincent Joralemon, Martin Shkreli Had a Point, LPE Project (Feb. 2026)
Vincent Joralemon, The Twelve-Thousand-Dollar Question: Who Picks Up the Tab for Psychedelics?, Health Affairs Forefront (Feb. 2026)
Julia Etkin & Vincent Joralemon, Regulating Psilocybin as Food, Not Drugs, Bill of Health, Harvard Law Petrie-Flom Center (Jan. 2026)
Vincent Joralemon, States, Not the FDA, Are Winning the Drug War, Bill of Health, Harvard Law Petrie-Flom Center (Jan. 2026)
Valena Beety, Jane Moriarty & Andrea L. Roth, Reference Guide on Forensic Feature Comparison Evidence, in Reference Manual on Scientific Evidence (4th ed. 2025)
Jeffrey Selbin, Suicide by Cop? How Junk Science and Bad Law Undermine Accountability for Killings by Police, 113 Calif. L. Rev. 1833 (2025)
Colleen V. Chien, Arti K. Rai & Jenna Clark, Molecular Diagnostic Patenting After Mayo v. Prometheus: An Empirical Analysis, 22 J. Empirical Legal Stud. 144 (2025)
Osagie K. Obasogie, Excited Delirium, Policing, and the Law of Evidence, 138 Harv. L. Rev. 1497 (2025)
Lawrence A. Haber, David H. Cloud, Chesa Boudin & Brie A. Williams, The Intersection of Climate Justice and Criminal Justice: Extreme Heat and Health Inequities in Carceral Facilities, 333 JAMA 843 (2025)
Jennifer L. Ohayon, Claudia Polsky & Megan R. Schwarzman, How a Right-to-Know Law Shifts Industry Away from Chemicals of Concern: The Case of California’s Proposition 65, 59 Env’t Sci. & Tech. 3344 (2025)
Lawrence A. Haber, Chesa Boudin & Brie A. Williams, Establishing National Standards for Carceral Health Care — The Federal Prison Oversight Act, 185 JAMA Internal Med. 135 (2025)
Vincent Joralemon, Selling Psychedelics, 28 Quinnipiac Health L.J. 330 (2025)
Mridula S. Raman, Prosecutorial Discretion and the Crime of Abortion, 43 Yale L. & Pol’y Rev. 171 (2024)
Kristin Knox, Megan R. Schwarzman, Ruthann Rudel, Claudia Polsky & Robin Dodson, Trends in NHANES Biomonitored Exposures in California and the United States Following Enactment of California’s Proposition 65, 132 Env’t Health Persp. 107007 (2024)
Khiara M. Bridges, Race in the Machine: Racial Disparities in Health and Medical AI, 110 Va. L. Rev. 243 (2024)
Student Scholarship
Notes and case studies by Berkeley Law students published in the Berkeley Technology Law Journal since the Center’s founding. Most began in the Law & Technology Writing Workshop; the 2024 special issue came out of the Center’s own Life Sciences Innovation Case Study Project.
Volume 40, Issue 3 (2025) — Annual Review
Monica Jeung, Antitrust and the Orange Book: An Analysis of Efforts to Reduce Improper Listings, 40 Berkeley Tech. L.J. 527 (2025)
Jesse Wang, Collateral Estoppel of PTAB Decisions in the Wake of United Therapeutics Corp. v. Liquidia Tech., Inc., 40 Berkeley Tech. L.J. 574 (2025)
Han K. D. Le, The Interaction of Obviousness-Type Double Patenting and Patent Term Adjustment, 40 Berkeley Tech. L.J. 608 (2025)
William R. Clark, Foreign Conduct as a Measure of Patent Damages After Brumfield v. IBG, 40 Berkeley Tech. L.J. 657 (2025)
Tyler Kotchman, Designing Around Obviousness: The Implications of LKQ v. GM Global, 40 Berkeley Tech. L.J. 689 (2025)
Karina A. Sanchez, Are Apps Products?: Consumer Software and Products Liability, 40 Berkeley Tech. L.J. 725 (2025)
Andra Cernavskis, Immunizing the Algorithm Only as Much as It Needs: Rethinking How Courts Analyze Algorithms Under Section 230, 40 Berkeley Tech. L.J. 766 (2025)
Siwen D. Cremean, AI Export Controls: Safeguard or a Straitjacket?, 40 Berkeley Tech. L.J. 809 (2025)
Ben Clifner, Hyter-Ritoriality: The Proper Extraterritorial Scope of the Defend Trade Secrets Act, 40 Berkeley Tech. L.J. 865 (2025)
Duane H. Yoo, Syntel v. TriZetto: Balancing Compensation and Deterrence in Trade Secret Remedies, 40 Berkeley Tech. L.J. 907 (2025)
Yasameen Joulaee, Developing Anti-Kickback Compliance Guidance at the Intersection of “Sponsored” and “Genetic Testing” Programs, 40 Berkeley Tech. L.J. 957 (2025)
Alexis Tatum, Ring the Alarm: An Analysis of the FTC’s Health Breach Notification Rule, 40 Berkeley Tech. L.J. 1010 (2025)
Volume 39, Issue 4 (2025) — Annual Review
Weijia (“Nina”) Zhang, IPR Estoppel (& “Estoppel-Like”) Provisions: Balancing Patent Quality and Quiet Title, 39 Berkeley Tech. L.J. 1223 (2025)
John Moore, Patent Enablement After Amgen v. Sanofi, 39 Berkeley Tech. L.J. 1285 (2025)
Nicole S. Boucher, Beyond Appropriation Art and Algorithms: Examining the Precedent Set by Warhol v. Goldsmith and Its Implications for Artificial Intelligence, 39 Berkeley Tech. L.J. 1325 (2025)
Devangini Rai, Jack Daniel’s v. VIP Products: Preserving the Rogers Test for Bad Spaniels, 39 Berkeley Tech. L.J. 1375 (2025)
Maya Darrow, Consumer Litigation as Privacy Regulation: Assessing the Merits of Session Replay Wiretapping Claims, 39 Berkeley Tech. L.J. 1419 (2025)
Gaurav Lalsinghani, Left in the Dark: Evaluating the FTC’s Limitations in Combatting Dark Patterns, 39 Berkeley Tech. L.J. 1463 (2025)
Tiana Wang, “Delicate Task”: Content Moderation and Intermediary Liability in a Post-DSA World, 39 Berkeley Tech. L.J. 1507 (2025)
Alex Le, Forum Shopping by Hyperlink: Internet Jurisdiction Under Mallory v. Norfolk Southern Railway Co., 39 Berkeley Tech. L.J. 1561 (2025)
Volume 39, Special Issue: Life Sciences Innovation Case Study (2024)
A Center project pairing Berkeley Law and UC Berkeley graduate students with case studies of breakthrough life-sciences inventions, developed through the Life Sciences & Innovation Workshop.
Allison A. Schmitt, Introducing the Life Sciences Innovation Case Study Project, 39 Berkeley Tech. L.J. 345 (2024)
Kaidi (Ted) Zhang, Serendipitous Lab Discovery to Commercial Blockbuster: The Invention of Lyrica, 39 Berkeley Tech. L.J. 393 (2024)
William P. Kasper, Innovation to Contain the HIV/AIDS Crisis: A Truvada Case Study, 39 Berkeley Tech. L.J. 425 (2024)
Vincent Joralemon, How Ketamine Became an Antidepressant, 39 Berkeley Tech. L.J. 498 (2024)
Christine R. O’Brien Laramy, The CAR-T Cell Therapy Innovation Drivers: A Yescarta Case Study, 39 Berkeley Tech. L.J. 554 (2024)
Caressa N. Tsai, The Invention of Next-Generation Sequencing, 39 Berkeley Tech. L.J. 613 (2024)
Volume 38, Issue 4 (2024) — Annual Review
Caressa N. Tsai, The Utility of Patent Eligibility, 38 Berkeley Tech. L.J. 1093 (2024)
Garreth W. McCrudden, Drugs, Deception, and Disclosure, 38 Berkeley Tech. L.J. 1131 (2024)
Sarah Davidson, Take a Picture: Copyright and State Sovereign Immunity, 38 Berkeley Tech. L.J. 1169 (2024)
Akshat Agrawal, Resolving Copyright’s Distortionary Effects, 38 Berkeley Tech. L.J. 1207 (2024)
Samantha Cox-Parra, Understanding Unicolors: Mistakes of Law Don’t Necessarily Invalidate Copyright Registration Certificates, 38 Berkeley Tech. L.J. 1249 (2024)
Brigitte Desnoes, Dangling the Carrot of Trademark Registration, 38 Berkeley Tech. L.J. 1273 (2024)
Danny Drane, Why It’s Time to Ban Geofence Searches in Light of United States v. Chatrie, 38 Berkeley Tech. L.J. 1307 (2024)
Leila Nasrolahi, Data Surveillance and Abortion Bans After Dobbs, 38 Berkeley Tech. L.J. 1341 (2024)
M. A. Katz, Clearly Repugnant: Correcting the Court’s Failed Approach to Antitrust Enforcement, 38 Berkeley Tech. L.J. 1373 (2024)
Zhudi Huang, Protecting the Competitive Process in Vertical Merger, 38 Berkeley Tech. L.J. 1405 (2024)
Utkarsh Srivastava, Gotta Catch ‘Em All: Legislative Overreach in Florida and Texas Anti-Moderation Laws, 38 Berkeley Tech. L.J. 1437 (2024)
Bogdan Belei, The Forgotten Public Interest Standard, 38 Berkeley Tech. L.J. 1469 (2024)